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BLC Expression in Pancreatic Islets
Causes B Cell Recruitment and
Lymphotoxin-Dependent Lymphoid Neogenesis
tures and B cell lymphomas (Mazzucchelli et al., 1999).
Two other constitutively expressed chemokines, SLC/
6Ckine/TCA4/Exodus2 and ELC/MIP3b, are made by
cells in the T cell zone and are ligands for CCR7 (Yoshie
et al., 1997; Cyster, 1999; Zlotnik et al., 1999). Genetic
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studies have established an important role for theseUniversity of California, San Francisco
molecules in dendritic cell and T cell trafficking to T cellSan Francisco, California 94143
areas of secondary lymphoid organs (FoÈ rster et al., 1999;
Gunn et al., 1999). In contrast to CXCR52/2 mice,
CCR72/2 mice develop all Peyer's patches and lymphSummary
nodes (FoÈ rster et al., 1999).
Parallel studies have established a critical role forCXCR5, the receptor for B lymphocyte chemoattrac-
tumor necrosis factor (TNF) and lymphotoxin (LT) in de-tant (BLC), is required for normal development of Pey-
velopment and maintenance of lymphoid architectureer's patches, inguinal lymph nodes, and splenic folli-
(reviewed in Fu and Chaplin, 1999). Mice deficient incles. To test the in vivo activity of BLC in isolation
LTa, which lack both the soluble LTa3 homotrimer asof other lymphoid organizers, transgenic mice were
well as the membrane LTa1b2 heterotrimer, show grossgenerated expressing BLC in the pancreatic islets. In
morphological changes, including the absence of Pey-addition to attracting B cells, BLC expression led to
er's patches and all lymph nodes (Fu and Chaplin, 1999).development of lymph node±like structures that con-
LTb2/2 animals have similar defects, although some mu-tained B and T cell zones, high endothelial venules,
cosal lymph nodes are retained (Fu and Chaplin, 1999).stromal cells, and the chemokine SLC. Development
Within the spleen of LTa- or LTb-deficient animals, whiteof these features was strongly dependent on B lym-
pulp cords are severely disorganized, and there is mini-phocytes and on lymphotoxin a1b2 and could be re-
mal development of stromal cells or expression of BLC,versed by blocking lymphotoxin a1b2. These findings
SLC, or ELC (Fu and Chaplin, 1999; Ngo et al., 1999).establish that BLC is sufficient to activate a pathway
Receptor-blocking studies have established a constitu-of events leading to formation of organized lymphoid
tive requirement for LTb receptor (LTbR) signaling totissue.
maintain follicular dendritic cell (FDC) networks and high
BLC and SLC expression (Mackay and Browning, 1998;
Introduction Ngo et al., 1999). The more broadly expressed cytokine,
TNFa, and its receptor, TNFR1, are also needed for
Recent studies have identified several chemokines that normal development of stromal cells and expression of
are constitutively expressed in lymphoid organs (Yoshie chemokines in B and T cell areas (Fu and Chaplin, 1999;
et al., 1997; Zlotnik et al., 1999). These ªlymphoidº che- Ngo et al., 1999).
mokines act as major cues for homeostatic trafficking The lack of certain lymphoid organs in LTa-, LTb-, and
within lymphoid tissues (Cyster, 1999). The chemokine B CXCR5-deficient mice as well as the similar disruption of
lymphocyte chemoattractant (BLC) (also called BCA-1) B cell follicles in TNF- and CXCR5-deficient animals
is produced constitutively by stromal cells in lymphoid suggests that LTa1b2, TNF, and CXCR5 act in a common
follicles and in vitro is an efficacious attractant of naive pathway of lymphoid neogenesis. Recently, B lympho-
B cells (Gunn et al., 1998; Legler et al., 1998). In addition, cytes have been recognized as an essential source of
BLC attracts some activated and memory T cells (Ansel LTa1b2 and TNF in the development of follicles and FDC
et al., 1999), while it shows no effect on naive T cells, networks (Fu et al., 1998; Gonzalez et al., 1998; Endres
peritoneal macrophages, or granulocytes. An important et al., 1999). The strong B cell±attracting activity of BLC
role for BLC in vivo is indicated by the defective traffick- together with the requirement of B cells as a source of
ing to lymphoid follicles of mature B cells deficient in LTa1b2 and TNF suggests that these cytokines may
the BLC receptor CXCR5 (formerly BLR-1) (FoÈ rster et function downstream of BLC in follicle development.
al., 1996). Splenic follicles fail to form in CXCR52/2 mice, However, because LTa1b2 and TNF are required for
and instead, B cells organize in ring-like structures normal BLC expression (Ngo et al., 1999), it has so far not
around the T zone. Interestingly, CXCR5-deficient ani- been possible to test whether these cytokines function
mals lack inguinal lymph nodes as well as most Peyer's downstream. B cells have also recently been found to
patches, suggesting an additional role of CXCR5 and be important for normal development of Peyer's patches
BLC in development of certain lymphoid organs (FoÈ rster (Golovkina et al., 1999), although it is not yet known
whether they are required here as a source of LTa1b2et al., 1996). In addition to its role as a lymphoid-tissue
or TNF.chemokine, BLC has been observed in Helicobacter py-
To study whether BLC is sufficient in vivo to mediatelori±induced gastric mucosa-associated lymphoid struc-
lymphocyte recruitment and possibly to lead to down-
stream events associated with lymphoid organ develop-³ To whom correspondence should be addressed (e-mail: cyster@
ment, we generated transgenic mice expressing BLC initsa.ucsf.edu).
b cells of the pancreatic islets. BLC expression was§ Present address: Genentech Inc., 1 DNA Way, South San Fran-
cisco, California 94080. found to be sufficient not only to mediate recruitment
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sufficient to promote lymphocyte recruitment, we exam-
ined hematoxylin-stained pancreas sections from RIP-
BLC transgenic mice and nontransgenic littermates. Ap-
proximately half of the islets in RIP-BLC transgenic mice
were infiltrated to various degrees with small nucleated
cells, whereas no infiltrates were detected in the con-
trols. By immunohistochemistry, many of the infiltrating
cells were identified as B2201 B lymphocytes (Figures
1B and 1D). Mice derived from each of the three RIP-
BLC transgenic lines showed similar B cell±rich infil-
trates, and for further experiments we focussed on one
of the lines, RIP-BLC1. To obtain a quantitative measure-
ment of the lymphocytes infiltrating the pancreas,
lymphoid cells were isolated from pancreas tissue by
collagenase digestion and density gradient separation.
Flow cytometric analysis revealed many lymphocytes in
the isolates from transgenic pancreas, with an enrich-
ment for B lymphocytes compared to peripheral blood
(Figures 2A and 2B). By contrast, very few lymphocytes
were obtained from nontransgenic pancreas (Figures
2A and 2B). On average, 90% of pancreas-infiltrating
lymphocytes in RIP-BLC1 transgenic mice were B2201
B cells, independent of mouse age. The B cells predomi-
nantly displayed a naive phenotype: CD692, IgM1,
Figure 1. Islet Expression of BLC Protein in RIP-BLC Transgenic CD191 (data not shown), IgD1, and CXCR51 (Figures
Mice Leads to Local B Cell Accumulation 3D and 2C). Although B cells predominated, CD4 and
(A±D) Cryosections from pancreas of 8-week-old nontransgenic lit- CD8 T cells were also present, being increased in num-
termate control mice (tg2; A and C) or RIP-BLC1 transgenic mice
ber z10-fold compared to littermate controls (Figures(tg1; B and D) were immunohistochemically stained for insulin (A
2A and 2B). Only a small fraction of CD41 or CD81 cellsand B) or BLC (C and D) in red and for B lymphocytes in brown
showed signs of acute activation (cell size, CD691; data(B220; A±D).
(E and F) A cryosection containing both peripheral lymph node (E) not shown). To determine whether the T cells could have
and noninfiltrated part of pancreas (F) from a single RIP-BLC1 trans- been directly recruited by BLC, we stained for the BLC
genic mouse was stained to detect BLC. Counterstain with hematox- receptor CXCR5. CXCR5 is expressed on mature B cells
ylin (blue) shows the B cell follicles of the lymph node (E).
and on some activated and memory T cells but not onMagnifications: 2003 (A±D); 503 (E±F).
naive T cells (FoÈ rster et al., 1994; Ansel et al., 1999).
The majority of the pancreatic CD41 and CD81 T cells
expressed CXCR5 (Figure 2C), indicating that many
of large numbers of B lymphocytes but also to cause of the T cells may have accumulated in response to
development of lymph node±like structures. These infil- BLC. Importantly, however, z30% of the T cells were
trates were strongly dependent on B lymphocytes and CXCR5low/neg, suggesting that ectopic BLC expression
the cytokine LTa1b2 in order to develop and to be main- leads to conditions that allow some T cells to enter the
tained. These findings establish that BLC can function pancreas by a mechanism other than in direct response
upstream of LTa1b2 in a pathway of lymphoid neo- to BLC.
genesis.
Ectopic BLC Expression Causes
Results Lymphoid Neogenesis
To further characterize the events that occur down-
Ectopic BLC Expression Mediates stream of pancreatic BLC expression, large-sized infil-
B Cell Recruitment trates in RIP-BLC transgenic mice were examined for
Three lines of transgenic mice were generated that carry the composition and organization of cells. In these infil-
the BLC cDNA under control of the rat insulin promotor trates, the islet architecture was often strongly dis-
(RIP). Staining of adjacent histological sections for insu- turbed, resembling severe insulitis (Figure 3A). Despite
lin and BLC revealed that all the islets in transgenic the extent of the infiltration, the mice did not show overt
animals were expressing BLC (Figures 1B and 1D), signs of diabetes, having normal blood glucose levels
whereas no BLC was detectable in islets of nontrans- and no obvious decrease in the number of b cells, even
genic littermates (Figures 1A and 1C). No BLC expres- when 16 months old (data not shown). In all the infil-
sion was found in kidney or liver of the transgenic ani- trates, B2201 B lymphocytes were predominant and lo-
mals (data not shown). By comparing the intensity of calized adjacent to the BLC (and insulin)-producing b
immunohistochemical staining in pancreas with staining cells (Figure 3A). Consistent with the flow cytometric
in lymph nodes, the pancreatic b cells were estimated analysis, the large infiltrates contained considerable
to be producing several-fold higher amounts of BLC numbers of CD31 T cells that localized more distant
than follicular stromal cells (Figures 1E and 1F). from the BLC-producing b cells than the B lymphocytes
(Figure 3B). CD11c1 dendritic cells were also present,To determine whether ectopic expression of BLC was
BLC-Induced Lymphoid Neogenesis
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Figure 2. Flow Cytometric Detection of Large Numbers of B Lymphocytes and Smaller Numbers of T Lymphocytes Infiltrating the Pancreas
of RIP-BLC Mice
(A±C) Lymphocytes were isolated from blood or perfused pancreas of 10- to 14-week-old nontransgenic littermates or RIP-BLC1 transgenic
mice and stained with antibodies to B220, CD4, CD8 and CXCR5.
(A) Representative dot plot analysis of the blood and pancreatic infiltrate (pancreas) of one nontransgenic (tg2) and one transgenic (tg1)
mouse. Numbers in the top right of each profile indicate the percentage of total cells within the corresponding gate. CD4 and CD8 were
stained with the same fluorophore and are identified by their low (CD4) or high (CD8) fluorescence intensity.
(B) Numbers of B2201, CD41, and CD81 lymphocytes isolated from pancreatic infiltrates of littermate controls (tg2) and RIP-BLC transgenic
(tg1) mice (mean 6 SD; four mice in each group).
(C) Representative histogram showing CXCR5 expression levels on CD41 and CD81 lymphocytes isolated from transgenic pancreas (thick
line) or similarly processed lymph node (thin line) from the same animal. As a comparison, CXCR5 levels on B2201 B lymphocytes isolated
from the same transgenic pancreas are shown (dotted line).
and in most cases the T cells and dendritic cells colocal- to explain the presence of CXCR52 T cells (Figure 2C)
and dendritic cells (Figure 3C) in the infiltrates.ized and clearly separated from the B cells (Figures 3B
and 3C). To test whether the BLC-induced lymphoid structures
formed part of the recirculation pathway of naive lym-The similarity between the organization of the infiltrate
and the normal compartmentalization of cells in second- phocytes, CFSE-labeled splenocytes from anti-hen egg
lysozyme (HEL) Ig-transgenic mice were intravenouslyary lymphoid organs prompted us to investigate other
features typical for lymphoid structures. An antibody transferred into RIP-BLC1 transgenic mice. After 12±15
hr the pancreas was removed and analyzed by immuno-specific for peripheral lymph node addressin, PNAd,
stained a considerable number of blood vessels within fluorescence. CFSE-labeled cells were found through-
out the pancreatic infiltrates of the RIP-BLC recipientthe lymphocytic infiltrates in RIP-BLC transgenic pan-
creas (Figure 3D). A subset of these vessels coex- mice (Figure 3H) in a frequency similar to peripheral
lymph nodes (Figure 3I). To establish whether newlypressed the mucosal addressin, MAdCAM (Figure 3E
and data not shown). More careful morphological analy- arriving lymphocytes would segregate into their respec-
tive T and B cell zones, staining with HEL was used tosis revealed that many of these vessels had thicker walls
than other surrounding vessels, suggesting that they distinguish the transferred B and T cells. Interestingly,
T/B segregation occurred as efficiently in the pancreatichad acquired the properties of lymph node HEVs. A
few blood vessels also expressed VCAM, an adhesion infiltrates as in the peripheral lymph node (Figures 3H
and 3I). Together, these findings indicate that expres-molecule typically found on activated endothelium (Fig-
ure 3G). Only a few scattered Mac-11, MOMA-11, or sion of BLC is sufficient to induce many features associ-
ated with secondary lymphoid organs, including bloodlarge MHC II1 macrophages were found (data not
shown). Staining for BP3, an antigen common to stromal vessel differentiation, vascular addressin upregulation,
stromal cell differentiation, chemokine induction, T/Bcells in B and T cell areas of lymphoid organs (McNagny
et al., 1991), revealed a dense network of cells extending segregation, and efficient recirculation of naive lympho-
cytes.through most of the infiltrate (Figure 3E). This stromal
network was negative for the FDC markers FDC-M1 and
CD35 except for occasional staining of vascular struc- BLC-Induced Lymphoid Neogenesis
Is B Cell Dependenttures by FDC-M1 (data not shown). Remarkably, staining
for the chemokine SLC was detectable within the infil- Although all the islets in transgenic animals express
BLC, development of HEV structures and stromal celltrates on a subset of HEVs as well as in a dense network
in the T cell±rich area (Figure 3F). This finding is likely networks was only observed in islets containing a
Immunity
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Figure 3. Large Infiltrates in RIP-BLC Transgenic Pancreas Show Many Characteristics of Lymph Nodes
(A±F) Immunohistochemical analysis on serial sections (A±C and D±F) of RIP-BLC1 transgenic pancreas. Sections were stained for the markers
indicated, and the color of the label corresponds to the color of the immunohistochemical reaction product. Examples shown are representative
of more than 50 large infiltrates examined.
(G) Example of VCAM expression in another large infiltrate. Note that the blue background staining in the exocrine tissue in some sections
was also seen in nontransgenic controls and is nonspecific.
(H and I) Immunofluorescence microscopy on pancreas (H) and lymph node (I) of a RIP-BLC1 transgenic mouse 14 hr after intravenous
injection of CFSE-labeled anti-HEL Ig-transgenic splenocytes. Transferred T lymphocytes show green cytoplasmic (CFSE) staining and can
be distinguished from transferred HEL-specific B lymphocytes that show both green cytoplasmic staining and red surface staining for HEL
antigen (H and I). Red background staining outside of infiltrate is nonspecific (H).
T, T cell±rich zone; B, B cell±rich zone (follicle). Magnifications: 1453 (A±C); 1003 (D±I).
lymphocytic infiltrate. These observations suggested by an increased number of B cells, T cells, and dendritic
cells as well as HEVs but little or no BP3 and SLC expres-that BLC was not able to directly induce development
of HEVs or stromal cells and that these effects were sion and varying T/B segregation. Finally, large-sized
infiltrates (more than z300 cells; see Figure 3) showedsecondary to B lymphocyte recruitment. This possibility
was tested by crossing the RIP-BLC1 transgene onto a well defined T and B cell±rich zones along with extensive
BP3 and SLC expression. In wild-type RIP-BLC1 trans-B cell±deficient (mM2/2) background (Kitamura et al.,
1991). To score the effect of B cell deficiency, we first genic mice, 5%±15% of the infiltrates were large, 40%±
50% medium, and 40%±50% small (Figure 4B).measured the frequency and size of pancreatic infil-
trates in a group of wild-type (mM1/1 and mM1/2) RIP- In B cell±deficient (mM2/2) RIP-BLC1 mice, very few
infiltrated islets were observed (Figures 4A, 4D, and 4E).BLC transgenic mice. Three stages of infiltrate com-
position were defined and will be described as small, Although the infiltrates in wild-type RIP-BLC1 mice are
B cell dominated (Figure 4C), the majority of infiltratesmedium, and large infiltrates. Small infiltrates (,30 cells/
infiltrate in a section) were made up mainly of B cells also contained T cells (Figures 4A and 4C). From these
observations, we estimate there was a 10-fold decreasewith very few T cells or dendritic cells and lacked fea-
tures such as PNAd or MAdCAM1 HEVs, BP31 stromal in the number of T cell±containing infiltrates in mice
lacking B cells (Figure 4A). An analysis of a large numbercells, or SLC expression (see Figure 1B). Medium-sized
infiltrates (between 30 and 300 cells) were characterized of hematoxylin-stained sections revealed that despite
BLC-Induced Lymphoid Neogenesis
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Figure 4. Lymphoid Neogenesis in RIP-BLC
Pancreas Is Largely B Cell Dependent
RIP-BLC1 transgenic mice on the mM2/2
background (B cell deficient) were analyzed
for the frequency (A), size (B), and histological
appearance (C±E) of the islet-associated infil-
trates.
(A and B) More than 350 islets of 3 transgenic
mM1/2 and mM2/2 littermates were stained
with hematoxylin and scored for the presence
of mononuclear cells associated with pancre-
atic islets (A, ªtotalº) and for the size of the
infiltrate (B; see Experimental Procedures for
details). In (A, ªT cellº) the frequency of islets
containing T cells was scored in mM1/1,
mM1/2, and mM2/2 mice by staining for CD4/8
(minimally 3 T cells per islet). More than 70
islets were analyzed.
(C±E) Representative immunohistochemical
staining of islets in RIP-BLC1 transgenic ani-
mals on the mM1/2 (C) or mM2/2 (D and E)
background.
I, islet of Langerhans. Magnification: 1003.
their low frequency, some infiltrates in the B cell± Together, these results suggest that LTa1b2±LTbR in-
teractions are not essential for the initial B cell infiltrationdeficient mice were able to progress to medium and
large sizes (Figure 4B). Closer analysis showed that but are required in a subsequent, potentially B cell±
mediated step that leads to HEV development, chemo-these infiltrates were composed mainly of CD41 cells,
with fewer CD81 and CD11c1 cells (Figure 4E and data kine expression, and more extensive infiltration or reten-
tion of T and B cells.not shown). A single very large infiltrate was observed
amongst 350 islets examined, and this infiltrate con-
tained HEVs (PNAd1, MAdCAM1) and an extensive stro- Maintenance of BLC-Induced Lymphoid Structures
mal cell network (data not shown). Overall, these results Depends on LTbR Signaling
indicate that B cells and signals given by B cells set The analysis of LTa2/2 and TNFR12/2 RIP-BLC mice
up the conditions for other cell types to immigrate or suggested a developmental role for the LTa1b2 hetero-
differentiate. trimer in this model system. In order to test whether
LTa1b2 was also required for the maintenance of estab-
lished islet-associated lymphoid structures, RIP-BLC1BLC-Induced Lymphoid Neogenesis
Is LTa Dependent transgenic mice were treated for 2 weeks with LTbR-Ig
fusion protein to inhibit signaling via LTbR. AdditionalTo explore the possible signals that are provided by
B lymphocytes, RIP-BLC1 mice were crossed onto animals were treated with TNFR1-Ig or, as a negative
control, with human LFA3-Ig. Treatment with the TNFR1-TNFR12/2 and LTa2/2 backgrounds. Analysis of TNFR12/2
RIP-BLC1 transgenic mice for the frequency and size Ig had no effect on the frequency or size of the infiltrates
(Figure 5C), consistent with the findings in TNFR1-defi-of pancreatic infiltrates showed no differences com-
pared to wild-type RIP-BLC1 littermates (Figure 5A), in- cient mice (Figure 5A). By contrast, treatment with LTbR-
Ig led to the disappearance of the large-sized infiltratesdicating that TNFR1 is not essential for the formation
of BLC-induced lymphoid structures. Similar analysis of and to a partial reduction in the size and number of the
medium-sized infiltrates (Figure 5C), similar to LTa2/2LTa2/2 RIP-BLC1 mice revealed that there was no change
in the total frequency of BLC-induced infiltrates, but RIP-BLC1 mice (Figure 5B). Immunohistochemical anal-
ysis of the largest infiltrates in LTbR-Ig- and LFA3-the average size of the infiltrates in LTa2/2 mice was
markedly reduced, despite BLC levels comparable to Ig-treated groups demonstrated that the LTbR-Ig treat-
ment disrupted most of the PNAd1 and MAdCAM1 HEVswild-type mice (Figure 5B and data not shown). No large
infiltrates were detected in over 350 islets examined, (Figures 6D and 6F, compare with 6C and 6E), BP31
stromal cell networks (Figure 6F versus 6E), and SLCand the number of medium infiltrates was 50% less.
Comparing examples of the largest infiltrates present in expression within the infiltrates (Figure 6H versus 6G).
Interestingly, constitutive SLC expression by lymphaticLTa2/2 RIP-BLC1 mice with those in wild-type RIP-BLC1
mice revealed not only the marked difference in size vessels in the pancreas was not affected by the LTbR-
Ig treatment (Figure 6G and 6H, insets), showing the(Figures 6A and 6B) but also the deficiency in accumula-
tion of T cells and dendritic cells (data not shown). In inhibitory effect was specific to the SLC expression in-
duced in the infiltrate. Lymphatic SLC expression alsoaddition, there was a strong reduction in fully developed
PNAd1 HEVs (Figures 6A and 6B), stromal cell networks, appeared normal in LTa2/2 mouse pancreas (data not
shown). In summary, treatment with LTbR-Ig fusion pro-and SLC expression (data not shown). The most devel-
oped structures in LTa-deficient mice were similar in tein was able to substantially reverse the BLC-induced
infiltration and recapitulate the phenotype observed incomposition to size-matched structures in wild-type
mice, consisting mainly of IgD1 B cells (see Figure 1B). LTa2/2 RIP-BLC1 transgenic mice.
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events (summarized in Figure 7). This pathway is likely
to play an important role within BLC-expressing inflam-
matory lesions (Mazzucchelli et al., 1999). BLC-medi-
ated recruitment of CXCR5-expressing cells that act as
a source of LTa1b2 is also likely to be part of the Peyer's
patch and inguinal lymph node developmental program
(FoÈ rster et al., 1996; Nishikawa et al., 1998).
The ectopic lymphoid structures that develop in RIP-
BLC transgenic animals are strikingly similar to struc-
tures observed previously in RIP-LTa and RIP-TNF
transgenic animals (see Kratz et al., 1996). Detailed char-
acterization of the RIP-LTa transgenic mice has shown
that large numbers of lymphocytes accumulate within
the islets and sort into B and T cell±rich areas (Kratz
et al., 1996). VCAM, ICAM1, MAdCAM, and PNAd are
upregulated (Kratz et al., 1996; Cuff et al., 1999), and
chemokine expression is also increased (Cuff et al.,
1999), although expression of BLC and SLC has not yet
been analyzed. Based on a combination of in vitro and
in vivo findings and on the broad expression pattern of
TNFR1, it is thought that LTa3 homotrimer made by the
pancreatic b cells directly induces VCAM, MAdCAM,
and ICAM1 expression on islet endothelial cells (Ware
et al., 1995; Kratz et al., 1996; Sacca et al., 1997; Cuff
et al., 1998, 1999). As expected from the lack of expres-
sion of LTb in pancreatic cells, LTa1b2 heterotrimer is
not required for many of the events that occur in the
RIP-LTa transgenic animals (Sacca et al., 1998). By con-
trast, in the RIP-BLC1 transgenic mice, the development
of infiltrates requires LTa1b2 but does not require
TNFR1 and, notably, can be reversed by LTbR-Ig treat-
Figure 5. Formation and Maintenance of Large Lymphoid Struc- ment (Figure 7). The similarity of the infiltrates in LTbR-
tures in RIP-BLC Transgenic Pancreas Is Dependent on Signals via Ig-treated and LTa2/2 RIP-BLC1 mice is in accord with
LTbR but Not TNFR1
previous studies on the involvement of the LTbR-
(A and B) Pancreas from RIP-BLC1 trangenic mice crossed onto LTa1b2 receptor-ligand pair in lymphoid development
the TNFR12/2 (A) or LTa2/2 (B) background were sectioned and
(Fu and Chaplin, 1999) and strongly supports the conclu-analyzed for the frequency and size of islet-associated, mononu-
sion that the active cytokine is LTa1b2 and not LIGHT,clear infiltrates using hematoxylin staining. Results were derived
an alternative LTbR ligand (Mauri et al., 1998). Thesefrom more than 350 islets of 3 transgenic mice in each group (7±12
weeks of age). findings fit well with previous studies showing that B
(C) The identical analysis as in (A) and (B) was performed on RIP- lymphocytes are a source of LTa and LTb (Fu et al.,
BLC1 transgenic animals that were injected either 3 times (TNFR1- 1998; Gonzalez et al., 1998; Endres et al., 1999), and they
Ig) or 4 times (LFA3-Ig, LTbR-Ig) with 100 mg of soluble fusion protein suggest a model in which BLC-recruited cells express
over 11 or 15 days, respectively. LFA3-Ig served as a negative con-
LTa1b2, and this cytokine then plays a limiting role introl. More than 300 islets from 3 animals in each group were analyzed
inducing downstream events (Figure 7). Consistent with(10±14 weeks of age). Immunohistochemical analysis was per-
this, the LTbR is expressed by multiple cell types, includ-formed on spleen and lymph nodes from each of the treated animals,
and disruption of FDC markers occurred in TNFR1-Ig- and LTbR- ing endothelial cells and fibroblasts, and it is highly ex-
Ig-treated animals as previously observed (Mackay and Browning, pressed within most organs, including pancreas (Hoch-
1998; Rennert et al., 1998). man et al., 1996; Degli-Esposti et al., 1997). It is
interesting to consider that despite the ability of TNFR1
Discussion signaling to induce formation of lymphoid structures
(see Sacca et al., 1998), this receptor is not essential
The above studies show that expression of the CXCR5 for infiltrate formation in the RIP-BLC transgenic animals
ligand BLC is sufficient to induce lymphoid neogenesis. (see Figure 5). However, it remains to be investigated
Development of BLC-induced lymphoid structures in whether TNF plays a necessary role in infiltrate develop-
pancreatic islets is strongly dependent on recruitment ment when LTa1b2 is absent, accounting for the incom-
of B lymphocytes and on the activity of the cytokine plete inhibition of medium-sized infiltrate formation in
LTa1b2. These findings contrast with ectopic expres- LTbR-Ig-treated and LTa2/2 RIP-BLC1 transgenic mice
sion studies for other chemokines, including MCP1, IL-8, (Figure 7). Overall, these observations indicate that
and KC/Gro, where the effects were limited to recruit- within infiltrates dominated by B lymphocytes, LTa1b2
ment of receptor-bearing cells (Lira et al., 1994; Simonet will be functionally more important than TNF or LTa3.
et al., 1994; Fuentes et al., 1995; Nakamura et al., 1995). Furthermore, they indicate that in addition to the pre-
Our findings with BLC provide a novel example of a viously described role of LTa1b2 in promoting BLC ex-
chemokine that is sufficient not only to cause cell recruit- pression (Ngo et al., 1999), this cytokine is likely to have
a role downstream of BLC in the pathway leading toment but also to induce a program of downstream
BLC-Induced Lymphoid Neogenesis
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Figure 6. Lymphotoxin a1b2 Is Required
Downstream of BLC-Mediated Signals for the
Development and Maintenance of HEVs,
Stromal Cell Networks, and SLC Expression
(A and B) Immunohistochemical analysis of
sections from RIP-BLC1 transgenic litter-
mates on a LTa1/2 (A) or LTa2/2 (B) back-
ground. Sections were stained for IgD (brown)
and PNAd (red). Faint blue staining in (A)
shows the hematoxylin-positive T cell±rich
zone in the infiltrate.
(C±H) Immunohistochemical analysis of sec-
tions from RIP-BLC1 transgenic mice treated
for 15 days with either LFA3-Ig (C, E, and G,
serial sections) or LTbR-Ig (D, F, and H, se-
rial sections) fusion protein. Sections were
stained with IgD or MAdCAM in brown and
PNAd, BP-3, or SLC in blue, as indicated.
One representative example of more than 15
stained infiltrates per group is shown. Insets
(in G and H) show transgene-independent
SLC expression in lymphatic vessels of both
LFA3-Ig- and LTbR-Ig-treated mice. The lym-
phatic vessels in each case are located adja-
cent to larger blood vessels that are SLC
negative. I, islet of Langerhans; wt, wild-type
RIP-BLC1 transgenic mice. Magnification:
1003 (A and B); 2003 (C±H).
development of CXCR5-dependent lymphoid struc- Development of the infiltrates in RIP-BLC transgenic
mice has many similarities to Peyer's patch develop-tures.
Many other cytokines have been ectopically ex- ment. The predominance of B cells and the high level
of BLC expression in the RIP-BLC infiltrates is similarpressed in pancreatic islets, including IFNa, IFNg, TGFb,
IL-2, IL-4, IL-6, IL-10 (see Mueller et al., 1997), and MCP1 to Peyer's patches. Peyer's patch frequency and size
is severely reduced in mice lacking either CXCR5 (FoÈ r-(Grewal et al., 1997). However, none of these transgenic
animals appear to develop the organized infiltrates seen ster et al., 1996) or B lymphocytes (Golovkina et al.,
1999), and they are totally absent in LTa1b2-deficientin animals expressing LTa, TNF, or BLC. Especially perti-
nent are the RIP-IL-4 and RIP-IL-6 transgenic animals, mice (Fu and Chaplin, 1999), while being only partially
affected by TNF and TNFR1 deficiency (Fu and Chaplin,which show B cell±rich accumulations but fail to develop
organized lymph node±like structures (Campbell et al., 1999). LTa1b2 is needed in at least two steps during
Peyer's patch organogenesis, with the first step being1994; DiCosmo et al., 1994; Mueller et al., 1997), sug-
gesting that B cell accumulation alone is not sufficient an inductive one around embryonic day 14 (Nishikawa
et al., 1998) and the second one occurring perinatallyto activate lymphoid neogenesis. These cytokines ap-
parently are unable to substitute for the need of the (Rennert et al., 1996; Yoshida et al., 1999). The late re-
quirement for LTa1b2 is consistent with a role for BLT/TNF signal and are also not able to induce these
cytokines to a sufficient degree. Taken together with cells as a LT source since lymphocytes emerge in the
periphery around birth (Rennert et al., 1996). From ourour findings, these observations support the notion that
cells recruited in response to BLC are a significant studies and the strong requirement for CXCR5 and B
cells, it can be proposed that the B cells recruited insource of lymphotoxin. A possibility that we are currently
investigating is that BLC directly induces LTa1b2 ex- response to BLC act as a critical source of lymphotoxin
in Peyer's patch development.pression in B lymphocytes.
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Figure 7. Summary of the Steps and Signals in BLC-Induced Lymphoid Neogenesis
The observations from the histological analysis of infiltrates found in RIP-BLC1 transgenic pancreas were compiled into a simplified model
showing the progression from a noninfiltrated islet to a large and highly organized infiltrate that disrupts the BLC-expressing islet of Langerhans
(which is a cluster of up to several hundred cells). Plain gray lines indicate a strong requirement, and a dotted gray line indicates a partial
requirement for a signal or cell type to progress to the next stage of infiltrate size and organization. For simplicity, stromal cells found in the
B cell±rich area of the infiltrate, and macrophages were omitted. In addition to the cell types shown, the progression of infiltrates to medium
and large size is accompanied by an upregulation of vascular addressins (PNAd, MAdCAM, and VCAM) on endothelium and by the induction
of SLC on endothelium and other cells, presumably stromal cells. These molecules are likely to contribute to the accumulation of naive T
cells and dendritic cells in the large infiltrates. It should be noted that while the RIP-BLC1 mice have shown a role for LTa1b2 downstream
of BLC, LTa1b2 also plays an important role upstream of BLC (Ngo et al., 1999).
Inguinal lymph nodes also fail to develop in CXCR5- likely to reinforce the compartmentalization. An impor-
tant implication of these findings is that once the loca-deficient mice (FoÈ rster et al., 1996). However, develop-
ment of these nodes is not affected in B cell±deficient tion of BLC production is defined, the position of the T
cell±rich compartment is fixed relative to this location.animals, indicating that BLC may act to recruit another
CXCR5-expressing cell type that promotes lymphoid Recently, it has been established that there are at least
two genes for SLC, a form predominantly expressedorganogenesis. Accumulating evidence suggests the
involvement of IL7R1CD41/2CD32 cells in this process within lymphoid organs and a second that is expressed
by lymphatic vessels in nonlymphoid organs (Vassileva(Mebius et al., 1997; Yokota et al., 1999; Yoshida et
al., 1999). Like B cells, these cells have been found to et al., 1999). We demonstrate here that expression of
SLC in lymphatic endothelium is lymphotoxin indepen-express both CXCR5 and lymphotoxin (Mebius et al.,
1997; Yoshida et al., 1999). Therefore, perhaps inguinal dent (see Figure 6), in contrast to the requirement for
LTa1b2 for SLC expression in secondary lymphoid tis-lymph node development depends on CXCR5/BLC-
mediated recruitment of IL7R1CD41/2CD32 cells, lead- sues (Ngo et al., 1999) and in the RIP-BLC islet infiltrates.
Which cell type(s) provides the LTa1b2 required for SLCing to a series of events similar to those observed in
the pancreatic infiltrates following B cell recruitment. expression in the infiltrates is under further investigation.
Interestingly, although SLC-expressing cells develop inSince development of all lymph nodes appears to de-
pend on IL7R1CD41/2CD32 cells (Yokota et al., 1999), the T cell areas of the islet infiltrate, extensive immuno-
histochemical analysis failed to reveal development ofBLC/CXCR5 may represent only one of the ligand/recep-
tor pairs involved in recruitment of these cells to sites FDC in the B cell±rich areas. Unfortunately, the large
amount of BLC produced by the pancreatic b cells madeof lymphoid organ development.
A striking feature of the large infiltrates in RIP-BLC it impossible to establish whether BLC was expressed
by the stromal cells present within the B cell±rich areas.transgenic mice is the separation of lymphocytes into
B and T±cell rich areas, with the B cell±rich areas always The failure to observe development of FDC made it im-
possible for us to test whether LTa1b2 is needed down-being found proximal to the BLC-expressing islet cells.
Their designation as B and T zones is supported by the stream of BLC for development of this cell type. FDC
development has been observed at sites of chronic au-rapid migration of transferred B and T cells into the
appropriate zones (see Figure 3H). How these compart- toimmune inflammation as well as within the infiltrates
of RIP-LTa transgenic animals (Kratz et al., 1996), andments become established is unclear, although it seems
possible that differences in the efficiency with which B their apparent absence in the RIP-BLC transgenic ani-
mals was unexpected. Perhaps the high BLC productionand T cells migrate to the proximity of BLC-producing
b cells may help initiate a relative separation of B and by the b cells in RIP-BLC transgenic animals acts in a
feedback inhibitory loop to limit FDC development.T cells. Induction of SLC expression, which occurs se-
lectively in the T cell±rich region (see Figure 3), is then The effector activities of B lymphocytes in immune
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Immunohistochemistry and Immunofluorescence Microscopyresponses are usually thought to be limited to antigen
For immunohistochemistry, cryostat sections (10 mm) were collectedpresentation and production of antibody. However, the
on superfrost plus slides (Fisher Scientific, Pittsburgh, PA), fixed forfinding that B cells are an important source of LTa, LTb,
10 min in acetone (48C), dried, and stored at 2208C. Slides were
and TNF for formation of follicles and FDCs (Fu et al., stained, developed, and analyzed as previously described (Ngo et
1998; Gonzalez et al., 1998; Endres et al., 1999) raised al., 1999), except for the following unconjugated antibodies: sheep
anti-IgD (Binding Site, San Diego, CA), rat IgM anti-PNAd (kindlythe possibility that B cells could have additional influ-
provided by Steve Rosen, University of California San Francisco,ences. We have now shown that lymphoid neogenesis
CA), rat anti-MAdCAM (PharMingen), rat anti-FDC-M1 (kindly pro-can be initiated as a result of BLC-mediated B cell re-
vided by Marie Kosco, Serono, Geneva, Switzerland), goat anti-cruitment to a nonlymphoid tissue. In addition to con-
mouse BLC and SLC (R&D Systems, Minneapolis, MN), and guinea
stitutive expression in the follicles of all secondary pig anti-insulin (Linco, St. Charles, MO); for biotinylated reagents:
lymphoid organs, expression of BLC has been reported hamster anti-CD3, mouse anti-Thy1.2 (Caltag), rat anti-Mac-1,
mouse anti-rat IgM (Caltag), hamster anti-CD11c, mouse anti-I-Ap,in the gastric mucosa±associated lymphoid structures
rat anti-VCAM (PharMingen), donkey anti-goat IgG (Jackson Labora-and B cell lymphomas that form in response to Helico-
tories), and goat anti±guinea pig IgG (Vector Laboratories, Bur-bacter pylori infection (Mazzucchelli et al., 1999). B cells
lingame, CA); for alkaline phosphatase±coupled reagents: swinepredominate in the infiltrates associated with several
anti-goat IgG (Caltag) and streptavidin-ABC (Vector Laboratories);
other chronic inflammatory diseases, such as rheuma- for peroxidase-coupled reagents: rabbit anti-sheep IgG (Jackson
toid arthritis and thryoiditis, and it will be important to Laboratories) and streptavidin (Amersham Pharmacia Biotech); and
for an additional substrate for alkaline phosphatase (Fast Bluedetermine whether BLC is induced in these diseases.
[Sigma]/Napthol AS-MX). Immunofluorescence microscopy wasAn important implication of our observations (Figure7)
performed as previously described (Ansel et al., 1999).is that compounds designed to inhibit BLC or the key
downstream mediator LTa1b2 have the potential to di-
Quantification of Immunohistochemistryminish the severity of BLC-expressing inflammatory le-
Every fifteenth 10 mm section from the pancreas was counterstained
sions. with hematoxylin and the number of mononuclear cells per islet
counted. Infiltrates were scored as noninfiltrated (,3 mononuclear
cells/islet), small (3±30 cells), medium (31±300 cells), and large (.300
Experimental Procedures cells). This procedure was applied for 80±140 islets per pancreas.
During the enumeration procedure, it was observed that some of
Transgenic Mice the large infiltrates appeared in more than one of the 10 mM sections
The full-length cDNA of murine BLC (Gunn et al., 1998) was cloned and sometimes in as many as six. Although this may have caused
into a ClaI site of the RIP7 promotor construct (Olson et al., 1998). the frequency of large infiltrates to be somewhat overestimated
Pronuclear injection of linearized RIP-BLC minigene lacking the vec- compared to the small- and medium-sized infiltrates, it does not
tor sequences was performed according to standard techniques affect comparisons made between groups of mice.
into fertilized B6D2F1 oocytes. Three founders with an approximate
copy number of 19, 9, and 4 copies were backcrossed to C57BL/6 Acknowledgments
mice. One line, RIP-BLC1 (19 copies), was backcrossed for 3±7
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